LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.68 | 21.74 | 3222 | 3418 | 0.9424 | 0.9838 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.68 | 21.74 | 3252 | 3418 | 0.9512 | 0.9863 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.68 | 21.74 | 64 | 3418 | 0.0187 | 0.1595 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.68 | 21.74 | 3176 | 3418 | 0.9290 | 0.9799 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.65 | 21.74 | 3514 | 3754 | 0.9360 | 0.9823 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.65 | 21.74 | 3548 | 3754 | 0.9451 | 0.9849 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.65 | 21.74 | 90 | 3754 | 0.0240 | 0.2107 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.65 | 21.74 | 3489 | 3754 | 0.9294 | 0.9804 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.62 | 21.74 | 3816 | 4150 | 0.9193 | 0.9779 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.62 | 21.74 | 3848 | 4150 | 0.9270 | 0.9801 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.62 | 21.74 | 484 | 4150 | 0.1166 | 0.5061 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.62 | 21.74 | 3915 | 4150 | 0.9432 | 0.9846 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.59 | 21.74 | 4063 | 4492 | 0.9045 | 0.9741 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.59 | 21.74 | 4125 | 4492 | 0.9183 | 0.9780 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.59 | 21.74 | 560 | 4492 | 0.1247 | 0.5257 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.59 | 21.74 | 4280 | 4492 | 0.9528 | 0.9875 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 49.56 | 21.74 | 4449 | 4838 | 0.9195 | 0.9786 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 49.56 | 21.74 | 4509 | 4838 | 0.9319 | 0.9820 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 49.56 | 21.74 | 1015 | 4838 | 0.2098 | 0.6370 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 49.56 | 21.74 | 4622 | 4838 | 0.9552 | 0.9883 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 51.53 | 21.74 | 4730 | 5150 | 0.9183 | 0.9785 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 51.53 | 21.74 | 4802 | 5150 | 0.9323 | 0.9823 | MN20160310_N01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 51.53 | 21.74 | 962 | 5150 | 0.1868 | 0.6168 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 51.53 | 21.74 | 5066 | 5150 | 0.9835 | 0.9958 | MN20160310_N01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 53.50 | 21.74 | 4998 | 5425 | 0.9211 | 0.9795 | MN20160310_N01 | F04 |